Chinese AI startup DeepSeek is reportedly close to raising $12 billion in a new funding round — far beyond its original $7.4 billion target — as it prepares for a stock market debut next year, Bloomberg reported on October 6. Battery giant CATL and tech giant Tencent are among the largest backers, with signed term sheets suggesting the round could approach $15 billion.
The oversubscribed round follows the release of DeepSeek's latest AI model, which strengthened its cost-performance position against OpenAI and Anthropic. Last month, The Information reported the company had more than doubled its annualized revenue run rate in a few months, putting it at $1 billion. Bloomberg describes the listing as one of the most anticipated Chinese market debuts in years.
The funding wave is spreading across China's AI leaders: rival Moonshot closed its final private round at a $50 billion valuation and is targeting a Hong Kong IPO in early 2027, while the round valued DeepSeek at 500 billion yuan (~$70 billion). The fundraising is reportedly set to fund at least 160,000 of Huawei's latest AI accelerators for a large Inner Mongolia data center — potentially the largest Huawei-chip AI cluster anywhere.
The Huawei detail is the one to watch. A 160,000-accelerator cluster built on Huawei chips — potentially the largest of its kind — is a direct answer to US export controls. For years the assumption in Washington was that cutting off advanced chips would slow China's AI progress; DeepSeek's answer, like Huawei's smartphone comeback before it, is to build the domestic alternative at staggering scale. Whether Huawei's accelerators can truly substitute for Nvidia's best in training frontier models remains the open technical question, but the capital flowing into the bet suggests Chinese investors believe the gap is closing.
The IPO angle matters too. A DeepSeek listing would be the first chance for public-market investors to own a pure-play Chinese frontier AI lab — and a real-time referendum on how the market values Chinese AI versus its US counterparts. With Moonshot also heading for Hong Kong at a $50 billion valuation, 2027 is shaping up as the year China's AI champions go public. The US-China AI race is increasingly being fought not just in labs, but in capital markets.
For the rest of the industry, DeepSeek's cost-performance reputation is the uncomfortable part. If a lab running on restricted hardware can match or undercut OpenAI and Anthropic on price-performance, it puts permanent downward pressure on AI margins worldwide. The $12 billion raise is not just about one company's IPO — it is funding for the competitor that keeps everyone else honest on price.
Watch the IPO pricing closely when it comes — it will tell you how global capital values Chinese AI ambition against American AI incumbency, in the most public way possible.